- US-listed companies
- BIORA THERAPEUTICS, INC.
- Income statement
BIORA THERAPEUTICS, INC. (BIORQ) Income statement
Market cap
$904.54
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Revenue | 74 | 1 | 0 | 0 |
| Revenue growth (%) | - | |||
| Cost of revenue | 93 | - | - | - |
| Gross profit | -19 | 1 | - | - |
| Gross margin (%) | - | - | ||
| Research & development | 48 | 46 | 24 | 30 |
| Selling, general & administrative | - | - | 38 | 37 |
| Operating margin (%) | ||||
| Operating expenses | 176 | 119 | 62 | 67 |
| Operating income | -195 | -118 | -62 | -67 |
| Income before tax | -230 | -179 | -49 | -124 |
| Pretax margin (%) | -309.6 | -14,325.6 | -16,147.5 | -3,110,600 |
| Provision for income taxes | -38 | -0 | -0 | -0 |
| Effective tax rate (%) | ||||
| Net income | -193 | -247 | -38 | -124 |
| Net income margin (%) | ||||
| Earnings per share | - | - | -5 | -7.87 |
| Diluted EPS | - | - | -5 | -7.87 |